Showing results (601-610 of 673) with videos related to
Sort By:
Pageof 68
British Journal of Haematology|February 22, 2023
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disordersMalgorzata Mikulska, Diletta Testi, Chiara Russo, et al.Open Forum Infectious Diseases|January 19, 2023
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting?Antonio Vena, Francesca Bovis, Stefania Tutino, et al.The Lancet. Infectious Diseases|December 17, 2020
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidancePhilipp Koehler, Matteo Bassetti, Arunaloke Chakrabarti, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 28, 2021
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical MycologyJuergen Prattes, Joost Wauters, Daniele Roberto Giacobbe, et al.Frontiers in Cardiovascular Medicine|November 16, 2020
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO)Francesca Polverino, Debra A Stern, Gaetano Ruocco, et al.Microorganisms|February 25, 2022
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian CentersDaniele Roberto Giacobbe, Stefano Di Bella, Silvia Dettori, et al.Infectious Diseases and Therapy|October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical TrialRichard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.Annals of Medicine|April 13, 2023
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impactDaniele Roberto Giacobbe, Emilio Di Maria, Alberto Stefano Tagliafico, et al.Open Forum Infectious Diseases|May 29, 2020
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe, et al.Pulmonology|January 20, 2023
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study)Luigi Vetrugno, Nadia Castaldo, Alberto Fantin, et al.Pageof 68